Other Issues

Browse Other Issues Content

Child-resistant packaging is used to reduce the risk of poisoning in children via the ingestion of potentially hazardous items including certain prescription and OTC medications, pesticides, and household chemicals.

Lawmakers should support the centralized progress made on ingredient evaluation, labeling, and packaging protections by specialized national children’s health agencies instead of allowing jurisdiction confusion that ultimately hinders healthcare advancement for all ages.

Regulation of Dietary Supplements covers marketing, manufacturing, labeling, and advertising enforced by FDA and the Federal Trade Commission. See these FAQs to learn more.

FDA Announcement of a proposed safety-based Administrative Order that proposes to add a skin allergy warning to labeling requirements for acetaminophen-containing drug products.

The bipartisan federal Combat Meth Epidemic Act strikes the proper policy balance between restricting pseudoephedrine access for illicit use without unduly burdening consumers seeking safe, effective cold relief. Therefore, state legislators should refrain from overriding federal guidelines requiring prescriptions for these legitimate over-the-counter medications.

Learn about the OTC review process, drug monographs, and time and extent applications.

Given that prescription medications filled at pharmacies are universally exempt from sales tax, over-the-counter drugs merit the same tax-free status.

Learn more about the issues CHPA addresses in the OTC medicine, dietary supplement, and OTC medical device industries.

Filter Results